SCHEMBL6350735

SCHEMBL6350735

COc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1S(=O)(=O)NCCc1ccc(N)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.51
MAPT P10636 4/20 0.49
POLB P06746 1/20 0.48
PKM P14618 1/20 0.48
TP53 P04637 2/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.47
CYP2C9 P11712 1/20 0.47
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
AKR1C2 P52895 2/20 0.44
AKR1C1 Q04828 2/20 0.44
PLK1 P53350 1/20 0.42
PLK3 Q9H4B4 1/20 0.42
AKR1C4 P17516 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353952 0.89 MEN1 (0.55) MAPTTP53LMNAMEN1KMT2A
SCHEMBL6358636 0.84 PRMT1 (0.50) MAPTMEN1KMT2AKDM4EAKR1C2
SCHEMBL6357674 0.81 HDAC2 (0.56) F10MAPTMEN1KMT2AAKR1C2
SCHEMBL6352333 0.81 MEN1 (0.52) MAPTPOLBPKMTP53LMNA
SCHEMBL11189465 0.81 PKM (0.68) F10MAPTPOLBPKMMEN1
SCHEMBL6834406 0.79 ALDH1A1 (0.44) POLBMEN1KMT2AKDM4EALDH1A1
SCHEMBL6929464 0.79 AKR1C2 (0.43) MAPTMEN1KMT2AKDM4EAKR1C2
SCHEMBL6390565 0.78 F10 (0.63) F10MAPTPOLBPKMTP53
SCHEMBL6349555 0.77 TP53 (0.51) MAPTTP53LMNAMEN1KMT2A
SCHEMBL6349295 0.76 MAPT (0.48) MAPTPOLBALDH1A1SMN1; SMN2AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 F10 2427/4885MAPT 4753/4885POLB 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.